Invion Limited Share Price
Stocks
IVX
AU000000IVX4
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:51:20 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0370 AUD | 0.00% |
|
+15.62% | -60.22% |
| 08-26 | Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Invion Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 4.04M 2.84M 2.55M 2.35M 2.14M 3.99M 270M 28.23M 11.21M 141M 10.67M 10.44M 449M | P/E 2025 |
-0.9x | P/E 2026 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 5M 3.51M 3.15M 2.91M 2.64M 4.94M 334M 34.91M 13.86M 175M 13.19M 12.91M 555M | EV / Sales 2025 |
-
| EV / Sales 2026 | 12.4x |
| Free-Float |
58.97% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IVX | Delayed | |
Deutsche Boerse AG
| 7C8 | Delayed |
| 18/09/24 | Invion Limited (ASX:IVX) Prostate Cancer Trial Results | AQ |
| 21/07/22 | Invion : Activities Report and Appendix 4C | PU |
| 20/06/22 | Invion : Notification regarding unquoted securities - IVX | PU |
| 20/04/22 | Invion : Activities Report and Appendix 4C | PU |
| 20/03/22 | Invion : Notification regarding unquoted securities - IVX | PU |
| 1 week | +15.62% | ||
| 1 month | -2.63% | ||
| 3 months | -19.57% | ||
| 6 months | -43.08% | ||
| Current year | -60.22% |
| 1 week | 0.03 |  | 0.04 |
| 1 month | 0.03 | | 0.04 |
| Current year | 0.03 | | 0.1 |
| 1 year | 0.03 | | 0.11 |
| 3 years | 0.03 | | 0.8 |
| 5 years | 0.03 | | 3.1 |
| 10 years | 0.03 | | 5.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thian Chew
CEO | Chief Executive Officer | - | 31/10/2020 |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | 12/07/2020 |
Brendon Lau
IRC | Investor Relations Contact | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thian Chew
CHM | Chairman | - | 30/11/2017 |
Alan Yamashita
BRD | Director/Board Member | 76 | 11/02/2019 |
Melanie Leydin
BRD | Director/Board Member | 53 | 30/08/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +15.62% | -60.22% | -93.83% | 2.84M | |
| -3.10% | -4.19% | +32.67% | +59.47% | 63.48B | |
| +2.73% | +2.29% | +12.94% | +83.95% | 54.55B | |
| -0.80% | +1.41% | +10.91% | +103.02% | 53.59B | |
| +3.06% | +0.84% | +27.89% | +57.46% | 44.75B | |
| +2.27% | -3.35% | +17.89% | +100.16% | 41.62B | |
| +0.55% | -4.28% | +219.68% | +913.41% | 39.91B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.47B | |
| +22.96% | +37.63% | +93.09% | +81.12% | 26.7B | |
| +3.72% | -6.23% | +26.01% | -8.28% | 23.36B | |
| Average | +3.05% | -1.34% | +39.19% | +134.11% | 38.04B | |
| Weighted average by Cap. | +2.22% | -1.27% | +46.20% | +159.01% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | 385K 271K 243K 224K 203K 380K 25.7M 2.69M 1.07M 13.47M 1.02M 994K 42.72M |
| Net income | -8.81M -6.19M -5.56M -5.13M -4.66M -8.7M -588M -61.55M -24.44M -308M -23.25M -22.76M -978M | -5.63M -3.96M -3.56M -3.28M -2.98M -5.56M -376M -39.36M -15.63M -197M -14.87M -14.55M -626M |
| Net Debt | -850K -598K -537K -496K -449K -840K -56.81M -5.94M -2.36M -29.78M -2.25M -2.2M -94.43M | 955K 672K 603K 557K 505K 944K 63.82M 6.68M 2.65M 33.45M 2.52M 2.47M 106M |
Employees
4
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | A$0.0370 | 0.00% | 13,000 |
| 26/10/26 | A$0.0370 | 0.00% | 718 |
| 23/10/26 | A$0.0370 | +12.12% | 149,330 |
| 22/10/26 | A$0.0330 | +3.13% | 157,500 |
| 21/10/26 | A$0.0320 | -11.11% | 387,993 |
- Stock Market
- Stocks
- IVX Stock
Select your edition
All financial news and data tailored to specific country editions
